Health Secretary Robert F. Kennedy Jr. has declined to clearly commit to supporting the newly nominated director of the Centers for Disease Control and Prevention on vaccine policy, raising fresh concerns about divisions within the administration over public health direction.
During a congressional hearing, Kennedy faced questions from lawmakers regarding whether he would back the incoming CDC chief, Dr. Erica Schwartz, particularly on issues related to vaccines. While he confirmed that he had discussed vaccine-related matters with her, he stopped short of offering full public support for her stance.
The hesitation comes amid broader tensions over vaccine policy in the United States. Kennedy, long associated with vaccine skepticism, has previously pushed for changes to immunization guidelines and oversight bodies, sparking criticism from medical experts and lawmakers.
Dr. Schwartz’s nomination by President Donald Trump is seen by some as an attempt to restore confidence in the CDC by placing a more conventional public health figure at its helm. However, uncertainty remains over how much independence she would have if confirmed.
The issue has been further complicated by recent legal and institutional challenges. A federal court ruling has disrupted the CDC’s vaccine advisory panel, creating uncertainty around vaccine recommendations and coverage across the country.
Kennedy’s ambiguous stance has fueled debate over the future of U.S. vaccine policy and the role of scientific leadership within federal health agencies. Analysts say the situation highlights ongoing friction between political leadership and public health experts at a time when clear guidance is considered critical.
